Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Source:http://linkedlifedata.com/resource/pubmed/id/9508199

Download in:

View as

General Info

PMID
9508199